964 related articles for article (PubMed ID: 9610754)
21. The effects of growth hormone replacement therapy on bone metabolism in adult-onset growth hormone deficiency: a 2-year open randomized controlled multicenter trial.
Bex M; Abs R; Maiter D; Beckers A; Lamberigts G; Bouillon R
J Bone Miner Res; 2002 Jun; 17(6):1081-94. PubMed ID: 12054164
[TBL] [Abstract][Full Text] [Related]
22. Individual igf-I responsiveness to a fixed regimen of low-dose growth hormone replacement is increased with less variability in obese compared to non-obese adults with severe growth hormone deficiency.
Yuen KC; Cook DM; Rumbaugh EE; Cook MB; Dunger DB
Horm Res; 2006; 65(1):6-13. PubMed ID: 16340214
[TBL] [Abstract][Full Text] [Related]
23. A low starting dose of genotropin in growth hormone-deficient adults.
Janssen YJ; Frölich M; Roelfsema F
J Clin Endocrinol Metab; 1997 Jan; 82(1):129-35. PubMed ID: 8989246
[TBL] [Abstract][Full Text] [Related]
24. The potential role of insulin-like growth factor 1, insulin-like growth factor binding protein 3 and bone mineral density in patients with chronic hepatitis C virus in Cairo, Egypt.
Raslan HM; Elhosary Y; Ezzat WM; Rasheed EA; Rasheed MA
Trans R Soc Trop Med Hyg; 2010 Jun; 104(6):429-32. PubMed ID: 20189618
[TBL] [Abstract][Full Text] [Related]
25. Effect of long-term growth hormone treatment on bone mass and bone metabolism in growth hormone-deficient men.
Bravenboer N; Holzmann PJ; ter Maaten JC; Stuurman LM; Roos JC; Lips P
J Bone Miner Res; 2005 Oct; 20(10):1778-84. PubMed ID: 16160735
[TBL] [Abstract][Full Text] [Related]
26. Growth hormone (GH) treatment of GH-deficient children increases serum levels of insulin-like growth factors (IGFs), IGF-binding protein-3 and -5, and bone alkaline phosphatase isoenzyme.
Ono T; Kanzaki S; Seino Y; Baylink DJ; Mohan S
J Clin Endocrinol Metab; 1996 Jun; 81(6):2111-6. PubMed ID: 8964836
[TBL] [Abstract][Full Text] [Related]
27. Effect of growth hormone replacement on BMD in adult-onset growth hormone deficiency.
Snyder PJ; Biller BM; Zagar A; Jackson I; Arafah BM; Nippoldt TB; Cook DM; Mooradian AD; Kwan A; Scism-Bacon J; Chipman JJ; Hartman ML
J Bone Miner Res; 2007 May; 22(5):762-70. PubMed ID: 17280527
[TBL] [Abstract][Full Text] [Related]
28. Impact of the growth hormone replacement on bone status in growth hormone deficient adults.
Kužma M; Kužmová Z; Zelinková Z; Killinger Z; Vaňuga P; Lazurová I; Tomková S; Payer J
Growth Horm IGF Res; 2014 Feb; 24(1):22-8. PubMed ID: 24382377
[TBL] [Abstract][Full Text] [Related]
29. Serum levels of insulin-like growth factor (IGF); IGF-binding proteins-3, -4, and -5; and their relationships to bone mineral density and the risk of vertebral fractures in postmenopausal women.
Yamaguchi T; Kanatani M; Yamauchi M; Kaji H; Sugishita T; Baylink DJ; Mohan S; Chihara K; Sugimoto T
Calcif Tissue Int; 2006 Jan; 78(1):18-24. PubMed ID: 16397738
[TBL] [Abstract][Full Text] [Related]
30. Fetal growth velocity, size in early life and adolescence, and prediction of bone mass: association to the GH-IGF axis.
Jensen RB; Vielwerth S; Frystyk J; Veldhuis J; Larsen T; Mølgaard C; Greisen G; Juul A
J Bone Miner Res; 2008 Mar; 23(3):439-46. PubMed ID: 17967132
[TBL] [Abstract][Full Text] [Related]
31. Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF-I) and IGF-binding protein-3.
Juul A; Kastrup KW; Pedersen SA; Skakkebaek NE
J Clin Endocrinol Metab; 1997 Apr; 82(4):1195-201. PubMed ID: 9100596
[TBL] [Abstract][Full Text] [Related]
32. Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults.
Marzullo P; Di Somma C; Pratt KL; Khosravi J; Diamandis A; Lombardi G; Colao A; Rosenfeld RG
J Clin Endocrinol Metab; 2001 Jul; 86(7):3001-8. PubMed ID: 11443159
[TBL] [Abstract][Full Text] [Related]
33. Effects of therapy with recombinant human growth hormone on insulin-like growth factor system components and serum levels of biochemical markers of bone formation in children after severe burn injury.
Klein GL; Wolf SE; Langman CB; Rosen CJ; Mohan S; Keenan BS; Matin S; Steffen C; Nicolai M; Sailer DE; Herndon DN
J Clin Endocrinol Metab; 1998 Jan; 83(1):21-4. PubMed ID: 9435411
[TBL] [Abstract][Full Text] [Related]
34. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
[TBL] [Abstract][Full Text] [Related]
35. Growth hormone treatment in adults with adult-onset growth hormone deficiency increases iliac crest trabecular bone turnover: a 1-year, double-blind, randomized, placebo-controlled study.
Brixen K; Hansen TB; Hauge E; Vahl N; Jørgensen JO; Christiansen JS; Mosekilde L; Hagen C; Melsen F
J Bone Miner Res; 2000 Feb; 15(2):293-300. PubMed ID: 10703931
[TBL] [Abstract][Full Text] [Related]
36. Serum insulin-like growth factor I (IGF-I), IGF-binding proteins 2 and 3, and the risk for development of malignancies in adults with growth hormone (GH) deficiency treated with GH: data from KIMS (Pfizer International Metabolic Database).
Popovic V; Mattsson AF; Gaillard RC; Wilton P; Koltowska-Häggström M; Ranke MB
J Clin Endocrinol Metab; 2010 Sep; 95(9):4449-54. PubMed ID: 20610598
[TBL] [Abstract][Full Text] [Related]
37. Effects of chronic renal failure and growth hormone on serum levels of insulin-like growth factor-binding protein-4 (IGFBP-4) and IGFBP-5 in children: a report of the Southwest Pediatric Nephrology Study Group.
Powell DR; Durham SK; Brewer ED; Frane JW; Watkins SL; Hogg RJ; Mohan S
J Clin Endocrinol Metab; 1999 Feb; 84(2):596-601. PubMed ID: 10022422
[TBL] [Abstract][Full Text] [Related]
38. Growth hormone, insulin growth factor-1, and igf binding protein-3 axis relationship with bone mineral density among healthy men.
Krassas GE; Papadopoulou P; Koliakos G; Konstantinidis T; Kalothetou K
Arch Androl; 2003; 49(3):191-9. PubMed ID: 12746097
[TBL] [Abstract][Full Text] [Related]
39. Impact of growth hormone status on body composition and the skeleton.
Mukherjee A; Murray RD; Shalet SM
Horm Res; 2004; 62 Suppl 3():35-41. PubMed ID: 15539797
[TBL] [Abstract][Full Text] [Related]
40. Intestinal calcium absorption and bone metabolism in young adult men with childhood-onset growth hormone deficiency.
de Boer H; Blok GJ; Popp-Snijders C; Sips A; Lips P; van der Veen E
J Bone Miner Res; 1998 Feb; 13(2):245-52. PubMed ID: 9495517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
